凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CASI 凯信远达

休市中 12-12 16:00:00 EST

0.8630

-0.0720

-7.70%

盘后0.8630

+0.00000.00%

18:40 EST

最高0.9387	最低0.8501	成交量1.82万
今开0.9350	昨收0.9350	日振幅9.48%
总市值1,773万	流通市值805.58万	总股本2,055万
成交额1.66万	换手率0.19%	流通股本933.47万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CASI","market":"US","secType":"STK","nameCN":"凯信远达","latestPrice":0.863,"timestamp":1765573200000,"preClose":0.935,"halted":0,"volume":18172,"hourTrading":{"tag":"盘后","latestPrice":0.863,"preClose":0.863,"latestTime":"18:40 EST","volume":4,"amount":3.4951,"timestamp":1765582842069},"delay":0,"floatShares":9334700,"shares":20548273,"eps":-2.984515,"marketStatus":"休市中","change":-0.072,"latestTime":"12-12 16:00:00 EST","open":0.935,"high":0.9387,"low":0.8501,"amount":16617.966904,"amplitude":0.094759,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.984515,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":834552000000,"exchange":"NASDAQ","adjPreClose":0.935,"preHourTrading":{"tag":"盘前","latestPrice":0.94,"preClose":0.9315,"latestTime":"08:16 EST","volume":761,"amount":715.5419694,"timestamp":1765545397175},"postHourTrading":{"tag":"盘后","latestPrice":0.863,"preClose":0.863,"latestTime":"18:40 EST","volume":4,"amount":3.4951,"timestamp":1765582842069},"volumeRatio":0.40350838227966945,"impliedVol":0.1099,"impliedVolPercentile":0.08},"requestUrl":"/m/hq/s/CASI/tweets","defaultTab":"tweets","newsList":[{"id":"2582308936","title":"凯信远达盘中异动 股价大涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582308936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582308936?lang=zh_cn&edition=full","pubTime":"2025-11-12 04:59","pubTimestamp":1762894787,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日04时59分，凯信远达股票出现波动，股价急速上涨5.60%。截至发稿，该股报1.42美元/股，成交量2.4033万股，换手率0.16%，振幅6.72%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为1.65%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112045947a49a8f0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112045947a49a8f0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2582872352","title":"凯信远达盘中异动 急速下跌5.07%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582872352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582872352?lang=zh_cn&edition=full","pubTime":"2025-11-10 23:15","pubTimestamp":1762787742,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日23时15分，凯信远达股票出现波动，股价大幅下挫5.07%。截至发稿，该股报1.31美元/股，成交量1.5851万股，换手率0.10%，振幅4.35%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.73%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111023154397608193&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111023154397608193&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2580491619","title":"凯信远达盘中异动 早盘股价大涨5.88%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580491619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580491619?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:32","pubTimestamp":1761917553,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日21时32分，凯信远达股票出现异动，股价快速上涨5.88%。截至发稿，该股报1.44美元/股，成交量4269股，换手率0.03%，振幅0.00%。凯信远达股票所在的生物技术行业中，整体跌幅为0.28%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031213233a6d90708&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031213233a6d90708&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2577149445","title":"凯信远达盘中异动 股价大涨8.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577149445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577149445?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:36","pubTimestamp":1761312962,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日21时36分，凯信远达股票出现异动，股价急速上涨8.70%。截至发稿，该股报1.75美元/股，成交量434股，换手率0.00%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.32%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213602a472dc94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213602a472dc94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2574857101","title":"凯信远达盘中异动 股价大涨6.99%报1.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574857101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574857101?lang=zh_cn&edition=full","pubTime":"2025-10-08 21:50","pubTimestamp":1759931457,"startTime":"0","endTime":"0","summary":"北京时间2025年10月08日21时50分，凯信远达股票出现异动，股价快速拉升6.99%。截至发稿，该股报1.99美元/股，成交量2.9766万股，换手率0.19%，振幅2.15%。凯信远达股票所在的生物技术行业中，整体涨幅为0.15%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100821505894bf2c99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100821505894bf2c99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2573798168","title":"凯信远达盘中异动 早盘大幅拉升8.11%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573798168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573798168?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:31","pubTimestamp":1759757470,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日21时31分，凯信远达股票出现异动，股价大幅拉升8.11%。截至发稿，该股报2.00美元/股，成交量1895股，换手率0.01%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.00%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213110a6aed94c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213110a6aed94c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2572062652","title":"凯信远达盘中异动 股价大涨5.71%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572062652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572062652?lang=zh_cn&edition=full","pubTime":"2025-10-03 21:31","pubTimestamp":1759498271,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时31分，凯信远达股票出现异动，股价大幅拉升5.71%。截至发稿，该股报1.85美元/股，成交量881股，换手率0.01%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.33%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213111a6ac2d00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213111a6ac2d00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2566607380","title":"凯信远达上涨2.14%，报2.39美元/股，总市值3706.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566607380","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566607380?lang=zh_cn&edition=full","pubTime":"2025-09-10 22:04","pubTimestamp":1757513081,"startTime":"0","endTime":"0","summary":"据交易所数据显示，9月10日，凯信远达盘中上涨2.14%，截至22:04，报2.39美元/股，成交6.26万美元，总市值3706.02万美元。财务数据显示，截至2025年03月31日，凯信远达收入总额624.0万美元，同比增长83.04%；归母净利润-1075.0万美元，同比减少12.83%。大事提醒：8月29日，凯信远达披露2025财年中报。资料显示，凯信远达医药公司是一家美国纳斯达克上市的生物医药公司,致力于在血液肿瘤领域为中国患者提供先进的疾病治疗方案。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/10220453060084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"1133012160","title":"CASI Pharmaceuticals Inc宣布Folotyn®在华进口药品注册证过期","url":"https://stock-news.laohu8.com/highlight/detail?id=1133012160","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133012160?lang=zh_cn&edition=full","pubTime":"2025-08-28 04:51","pubTimestamp":1756327877,"startTime":"0","endTime":"0","summary":"CASI Pharmaceuticals Inc（凯信远达）宣布其产品Folotyn®在中国的进口药品注册证已过期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2558166157","title":"凯信远达盘中异动 急速拉升5.25%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558166157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558166157?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:17","pubTimestamp":1754925464,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时17分，凯信远达股票出现波动，股价急速上涨5.25%。截至发稿，该股报1.72美元/股，成交量6.7213万股，换手率0.43%，振幅6.48%。凯信远达股票所在的生物技术行业中，整体涨幅为0.45%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811231745a4823d7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811231745a4823d7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2557929833","title":"凯信远达盘中异动 快速上涨6.67%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557929833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557929833?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:34","pubTimestamp":1754400863,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时34分，凯信远达股票出现异动，股价急速上涨6.67%。截至发稿，该股报2.08美元/股，成交量34.277万股，换手率2.21%，振幅13.85%。凯信远达股票所在的生物技术行业中，整体跌幅为3.28%。其相关个股中，Y-Mabs Therapeutics, Inc.、Adaptimmune Therapeutics Plc、Shattuck Labs, Inc.涨幅较大，Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为102.76%、76.64%、62.97%，振幅较大的相关个股有Shattuck Labs, Inc.、凯信远达、Plus Therapeutics, Inc.，振幅分别为14.41%、13.85%、12.18%。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213423973567d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213423973567d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2556821633","title":"凯信远达盘中异动 急速拉升14.73%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556821633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556821633?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:32","pubTimestamp":1754314359,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时32分，凯信远达股票出现波动，股价急速上涨14.73%。截至发稿，该股报1.48美元/股，成交量190.968万股，换手率12.33%，振幅15.35%。凯信远达股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2250.63%、807.74%、390.30%，振幅较大的相关个股有Psyence Biomedical Ltd.、凯信远达、Bioxcel Therapeutics, Inc.，振幅分别为25.21%、15.35%、13.50%。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213239a4748ff4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213239a4748ff4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2554366777","title":"凯信远达盘中异动 早盘大幅拉升7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554366777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554366777?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:37","pubTimestamp":1753709842,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时37分，凯信远达股票出现异动，股价急速上涨7.09%。截至发稿，该股报1.59美元/股，成交量388股，换手率0.00%，振幅0.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.23%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213722a467dbba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213722a467dbba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2551296571","title":"凯信远达盘中异动 早盘大幅跳水6.55%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551296571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551296571?lang=zh_cn&edition=full","pubTime":"2025-07-16 22:29","pubTimestamp":1752676190,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日22时29分，凯信远达股票出现异动，股价大幅跳水6.55%。截至发稿，该股报1.21美元/股，成交量4049股，换手率0.03%，振幅1.54%。凯信远达股票所在的生物技术行业中，整体涨幅为1.05%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162229509544f7f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162229509544f7f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2550603243","title":"凯信远达7月10日成交额为2.57万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550603243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550603243?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:28","pubTimestamp":1752197324,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，凯信远达成交额为2.57万美元，成交额较昨日减少18.52%，当日成交量为1.84万股。凯信远达于2025年7月10日涨1.42%，报1.43美元，该股过去5个交易日涨7.52%，年初至今跌49.47%，过去60日跌26.67%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711092851a443901b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711092851a443901b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2550087650","title":"凯信远达盘中异动 下午盘快速下跌6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550087650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550087650?lang=zh_cn&edition=full","pubTime":"2025-07-10 03:18","pubTimestamp":1752088683,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日03时18分，凯信远达股票出现异动，股价急速下挫6.05%。截至发稿，该股报1.32美元/股，成交量1.9957万股，换手率0.13%，振幅9.25%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为1.42%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710031803979ffe16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710031803979ffe16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2549530031","title":"凯信远达盘中异动 早盘大幅下跌5.38%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549530031?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:43","pubTimestamp":1751895832,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时43分，凯信远达股票出现异动，股价大幅下跌5.38%。截至发稿，该股报1.23美元/股，成交量2807股，换手率0.02%，振幅0.00%。凯信远达股票所在的生物技术行业中，整体跌幅为0.60%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707214353a43bfb61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707214353a43bfb61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2548883130","title":"凯信远达盘中异动 快速拉升6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548883130?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:08","pubTimestamp":1751382507,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时08分，凯信远达股票出现波动，股价大幅拉升6.50%。截至发稿，该股报1.26美元/股，成交量4110股，换手率0.03%，振幅3.39%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.55%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701230828a4c93f6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701230828a4c93f6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2547090691","title":"凯信远达盘中异动 早盘急速下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547090691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547090691?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:34","pubTimestamp":1751290475,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时34分，凯信远达股票出现异动，股价大幅下挫5.17%。截至发稿，该股报1.14美元/股，成交量8927股，换手率0.06%，振幅3.33%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.21%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213435a726447c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213435a726447c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2546789357","title":"凯信远达6月27日成交额为3.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546789357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546789357?lang=zh_cn&edition=full","pubTime":"2025-06-28 09:27","pubTimestamp":1751074020,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，凯信远达成交额为3.79万美元，成交额较昨日减少24.64%，当日成交量为3.06万股。凯信远达于2025年6月27日跌7.69%，报1.2美元，该股过去5个交易日跌9.77%，年初至今跌57.6%，过去60日跌42.86%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628092708a4c23373&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628092708a4c23373&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.casipharmaceuticals.com","stockEarnings":[{"period":"1week","weight":-0.1011},{"period":"1month","weight":-0.4048},{"period":"3month","weight":-0.6215},{"period":"6month","weight":-0.531},{"period":"1year","weight":-0.7189},{"period":"ytd","weight":-0.6951}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"凯信远达医药公司于1991年注册成立，是一家在开曼群岛注册成立的豁免公司。该公司是一家生物制药公司，专注于在中国、美国和世界各地开发和商业化创新疗法和医药产品。公司打造了一家完全一体化、世界一流的生物制药公司，致力于创新和其他治疗产品的成功开发和商业化。公司业务发展战略目前的重点是通过许可获得额外的靶向药物和免疫肿瘤疗法，这将扩大血液学/肿瘤学特许经营权。","yearOnYearQuotes":[{"month":1,"riseRate":0.689655,"avgChangeRate":0.165398},{"month":2,"riseRate":0.344828,"avgChangeRate":-0.010081},{"month":3,"riseRate":0.310345,"avgChangeRate":-0.000942},{"month":4,"riseRate":0.37931,"avgChangeRate":0.030827},{"month":5,"riseRate":0.241379,"avgChangeRate":0.04909},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.032316},{"month":7,"riseRate":0.266667,"avgChangeRate":-0.055599},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.00385},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.001431},{"month":10,"riseRate":0.6,"avgChangeRate":0.088727},{"month":11,"riseRate":0.366667,"avgChangeRate":0.020646},{"month":12,"riseRate":0.233333,"avgChangeRate":-0.100306}],"exchange":"NASDAQ","name":"凯信远达","nameEN":"CASI Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯信远达,CASI,凯信远达股票,凯信远达股票老虎,凯信远达股票老虎国际,凯信远达行情,凯信远达股票行情,凯信远达股价,凯信远达股市,凯信远达股票价格,凯信远达股票交易,凯信远达股票购买,凯信远达股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}